Fdc
National List of Essential Medicines: All that you need to know about it
The Ministry of Health and Family Welfare released the first NLEM in 1996. It contained 279 medicines. The list was subsequently revised in 2003 and had 354 medicines
 "National List of Essential Medicines: All that you need to know about it")
Glenmark Pharma launches first FDC drug Indamet for asthma patients
Glenmark Pharmaceuticals on Thursday said it has launched a novel fixed-dose combination (FDC) drug in the country for patients with uncontrolled asthma. The Mumbai-based drug major has launched - Indacaterol + Mometasone FDC under the brand name Indamet. The drug will be available in three strengths with a fixed dose of Indacaterol 150 mcg and variable doses of Mometasone 80 mcg, 160 mcg and 320 mcg to be taken once daily. "Respiratory is a key focus area for Glenmark, and the company leads from the front in providing access to the latest treatment options to patients. "We are proud to introduce this novel fixed-dose combination Indamet, which is the first of its kind in India, offering an affordable treatment option to both adults and adolescents 12 years of age and older suffering from uncontrolled asthma," Glenmark Pharmaceuticals Group Vice President & Head (India Formulations) Alok Malik said in a statement. The drug maker is the first company in India to market the FDC of .
 "Glenmark Pharma launches first FDC drug Indamet for asthma patients")
FDC surges 8% as board to consider share buyback proposal
The company's board will meet on February 9, 2022 to consider the proposal for buyback of equity shares of the company through tender offer route.
 "FDC surges 8% as board to consider share buyback proposal")
Nifty outlook & stock picks by Nilesh Jain of Anand Rathi: Buy FDC, Cyient
The momentum indicator for FDC has reversed from the overbought territory which hints of further positive momentum in the counter
 "Nifty outlook & stock picks by Nilesh Jain of Anand Rathi: Buy FDC, Cyient")
FDC jumps 6% after launching 2 variants of Covid-19 drug Favipiravir
The price per tablet is Rs 55 for both the variants
 "FDC jumps 6% after launching 2 variants of Covid-19 drug Favipiravir")
FDC at 52-wk high as Goa plant gets GMP certificate from UK drug regulator
In the past two months, FDC has outperformed the market by surging 25 per cent, after reporting a healthy September quarter earnings (Q2FY20)
 "FDC at 52-wk high as Goa plant gets GMP certificate from UK drug regulator")
FDC, V-Mart Retail hit record highs in weak market
FDC rallied 11% to Rs 319, while V-Mart surged 7% to Rs 1,960 on the BSE in intra-day trade.
 "FDC, V-Mart Retail hit record highs in weak market")
FDC hits 52-week high as board approves buyback; strong Q3 results
The stock hit a 52-week high of Rs 280, up 10%, extending its previous days 6% surge, after the board approved buyback proposal at a price of Rs 350 per equity share through tender offer.
 "FDC hits 52-week high as board approves buyback; strong Q3 results")
FDC gains 7% ahead of board meet for share buyback
The stock was up 7% to Rs 256 on BSE ahead of board meeting today to consider share buyback proposal and unaudited financial results for the quarter ended December 2017.
 "FDC gains 7% ahead of board meet for share buyback")
FDC gains after USFDA completes inspection of Waluj unit
The stock was up 6% to RS 195 on the BSE.
 "FDC gains after USFDA completes inspection of Waluj unit")
FDC receives two observations from USFDA for Waluj plant
USFDA carried out the audit in relation to cGMP norms and the ANDA filed by the company for dorzolamide ophthalmic solution from the unit
 "FDC receives two observations from USFDA for Waluj plant")
Delhi HC continues hearing arguments in FDC pharma ban case
Controversy arose after Centre banned 344 fixed dose combination drugs
 "Delhi HC continues hearing arguments in FDC pharma ban case")
